Status:
COMPLETED
Bilateral DLPC tDCS in Drug-resistant Migraine
Lead Sponsor:
Clínica de Intervención en Neurociencias
Conditions:
Migraine
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to study and describe the effects of bilateral tDCS applied to dorso-lateral-prefrontal cortex (DLPC) in patients with drug-resistant migraine in terms of reduction ...
Eligibility Criteria
Inclusion
- diagnosis of high-frequency and/or chronic migraines, according to the diagnostic criteria of the ICHD-III,
- failure to more than 3 preventive drugs
- stable pharmacological treatment (\> 6 months without changes),
- absence of other neurological or medical pathological conditions,
- written informed consent.
Exclusion
- seizures
- significant cognitive impairment that prevents following orders and understanding instructions (Mini-Mental State Examination \< 23)
- pregnancy
- aphasia or limitations in communication,
- metallic cranial implants
- another neurological or psychiatric pathology
- diagnosis of another type of migraine.
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06079801
Start Date
October 1 2021
End Date
August 31 2023
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinica de Intervencion en Neurociencias
Talavera de la Reina, Toledo, Spain, 45600